NEW YORK (GenomeWeb) – Arrayjet said today that it has secured an approximately $250,000 contract with the New York Bioscience Cluster for microarray instrumentation, printing, and expertise.

The Bronx-based NYBC provides gene expression research services for diseases and disorders related to immunology, cancer, diabetes, and liver function, and will use Arrayjet's Marathon Argus high-throughput bioprinter for much of this work, Edinburgh, Scotland-based Arrayjet said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
21
Sponsored by
Roche

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.